The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTmt Investments Regulatory News (TMT)

Share Price Information for Tmt Investments (TMT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.74
Bid: 3.60
Ask: 3.80
Change: -0.11 (-2.89%)
Spread: 0.20 (5.556%)
Open: 3.74
High: 3.74
Low: 3.74
Prev. Close: 3.81
TMT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment in Virool

30 Aug 2012 09:28

RNS Number : 0847L
TMT Investments PLC
30 August 2012
 

30 August 2012

 

TMT INVESTMENTS PLC

("TMT" or the "Company")

 

Investment in Virool, Inc.

 

The Board of TMT is pleased to announce the completion of an investment in Virool, Inc. Incorporated in Delaware, Virool, Inc. ("Virool") has developed a self-service platform that allows video creators to distribute videos that are over 30 seconds long to targeted audiences across Virool's network of online publishers, blogs, social games and mobile apps. Virool has developed an application that makes it very easy for publishers on Facebook, iOS, Android, blogs or other media channels to plug into the Virool network and start making money by providing advertising space.

 

TMT's investment consists of a US$400,000 unsecured uncapped convertible promissory note in Virool (the "Note") on the following terms:

 

·; Interest rate - 2% per annum.

·; Term - the Note will be repayable in whole or in part at par at TMT's option 24 months from the date of issuance of the Note.

·; Conversion -

o Optional conversion: any outstanding principal and unpaid accrued interest on the Note may be converted after 24 months at TMT's option at an equity valuation equal to an agreed open market value.

o Automatic conversion: any outstanding principal and unpaid accrued interest on the Note will be automatically converted into Virool's equity securities upon the earliest of (i) closing of the next equity financing of at least US$5,000,000, or (ii) a change of control of Virool, in either case at an equity valuation equal to 80% of the equity valuation of Virool applicable to the next equity financing or change of control.

 

Definitive agreements for the transaction were entered into, and the transaction was completed, yesterday.

 

"There are over a million videos uploaded to YouTube every day, with 95% of them getting less than 1,000 views," says Alexander Debelov, co-founder and CEO of Virool. "No matter how funny or appealing your video is, it is not going to go viral unless enough people discover and begin sharing it. That's where Virool comes in. Virool helps anyone with a video to get noticed. Although Virool was launched only a few months ago, the company is seeing explosive growth, both in terms of the number of videos it serves and the amount of revenue it is generating. It already has over 7,000 advertisers using the platform, and is adding about 250 new advertisers every day, providing its advertising clients with more than half a million video views a day."

 

Alexander Debelov graduated from Babson College with a degree in Technology Entrepreneurship and Design. At Babson, he was recognized as the Most Outstanding Entrepreneurship Student, winner of John H. Muller Business Plan competition and was named amongst Top 5 College Entrepreneurs by Entrepreneur Magazine in 2010. While at Babson, Alexander co-founded The Kairos Society, world's largest student entrepreneurship organization today.

 

Alexander Selegenev, Executive Director of TMT Investments PLC, commented: "The strong growth in video adverts means that it is hard for a company to deliver its videos to the right audiences. Virool's video advertising service is very well positioned to become an "AdWords for video", especially for small and medium-sized advertisers, offering a highly targeted, transparent and results-based service."

 

To date, Virool has raised capital from such recognized venture capitalists as Y-Combinator (incl. Andreessen Horowitz, SV Angel, Yuri Milner, and General Catalyst), Thomvest Ventures, 500Startups, NetPrice, Global Venture Alliance, Plug and Play Ventures, Ryan Tu, Paul Buccheit, Garry Tan, Harj Taggar, and Alexis Ohanian.

 

Virool did not have any financial accounts in respect of the year ended 31 December 2011.

 

 

For further information contact:

 

TMT Investments Plc

Mr. Alexander Selegenev

www.tmtinvestments.com

 

+44 1534 281 843

alexander.selegenev@tmtinvestments.com

 

ZAI Corporate Finance Ltd.

NOMAD and Broker

Marc Cramsie/Irina Lomova

 

+44 20 7060 2220

Kinlan Communications

David Hothersall

 

Tel. +44 20 7638 3435

davidh@kinlan.net

 

About TMT Investments

 

The Investment Policy & Strategy

The Company's objective is to generate an attractive rate of return for Shareholders, predominantly through capital appreciation, by taking advantage of opportunities to invest in the TMT Sector. The Company aims to provide equity and equity-related investment capital, such as convertible loans, to private companies which are seeking capital for growth and development, consolidation or acquisition, or as a pre-IPO financing.

 

In addition, the Company intends to invest in publicly traded equities which have securities listed on a stock exchange or over-the-counter market. These investments may be in combination with additional debt or equity-related financing, and in appropriate circumstances in collaboration with other value added financial and/or strategic investors.

 

The Company is not geographically restricted in terms of where it will consider making investments. It will consider any geographical area, to the extent that the investment fits within the Company's investment criteria. The Directors and Consultants have expertise in emerging markets and, in particular, in Russia and the Commonwealth of Independent States. The Company will not be subject to any borrowing or leveraging limits.

 

Private Companies

The Company will target small and mid-sized companies and will seek to secure at least blocking stakes and board representation, where it considers that the Company and/or an investee company would benefit from such an appointment. The Company will consider making equity investments in lower than blocking stakes only where it sees ways to increase the stakes to blocking or controlling stakes at a later date. Each investment is expected to be at least US$250,000.

 

The investments targeted by the Company will aim to support rapidly-growing private companies to increase market share and achieve long-term shareholder value. It is envisaged that if the Company invested in a private company prior to that company listing on a stock market, the Company would retain a part of its investment in the listed entity going forward. The Company intends to work closely with the management of each investee company to create value by focusing on driving growth through revenue creation, margin enhancement and extracting cost efficiencies, as well as implementing appropriate capital structures to enhance returns.

 

Public Companies

When investing in public equities, the Company will seek to select companies with a dominant market share or strong growth potential in their respective segments. No restrictions will be placed on the size of public companies in which the Company may make an investment. The Directors intend to make investments in companies or businesses with attractive valuation, growth potential, with competent and motivated management, which enjoy brand recognition, have scalable business models, have strong relationships with customers and have in place transparent accounting policies.

 

Realisation of Returns

The Directors will, when appropriate, consider how best to realise value for Shareholders whether through a trade sale, flotation or secondary refinancing of the investee companies. The proposed exit route will form a key consideration of the initial investment analysis.

 

The Company expects to derive returns on investments principally through long-term capital gains and/or the payment of dividends by investees. The primary ways in which the Company expects to realise these returns include: (a) the sale or merger of a company; (b) the sale of securities of a company by means of public or private offerings; and (c) the disposal of public equity investments through the stock exchanges on which they are listed.

 

For private investee companies the Company believes that its typical investment holding period should provide sufficient time for investee companies to adequately benefit from the capital and operational improvements resulting from the Company's investment. The targeted holding period shall be reviewed on a regular basis by the Company, but it is expected that this will typically be between two to four years. For public equities the Company's objective is to maximise capital appreciation. Following the acquisition, the Company will continue to conduct extensive research and monitoring of the investment. Importance will be placed on the timing of any disposal which will follow a thorough review of market conditions and those reports and sources that are available to investors. Should the Company consider that the capital appreciation of a particular public equity investment has reached its peak or is likely to or has begun to decline, then the Company will consider the sale of that investment.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCVBLBXLVFLBBD
Date   Source Headline
15th Oct 202012:15 pmRNSHolding(s) in Company
15th Sep 20207:00 amRNSHalf-year Report
30th Jul 20204:10 pmRNSResult of AGM
22nd Jul 20207:00 amRNSChange of venue for AGM
15th Jul 20207:00 amRNSPDMR Shareholding
15th Jul 20207:00 amRNSHolding(s) in Company
29th Jun 202011:30 amRNSChange of registered address
25th Jun 20201:35 pmRNSHolding(s) in Company
24th Jun 20203:49 pmRNSHolding(s) in Company
28th May 20207:00 amRNSPortfolio Update
26th May 20203:25 pmRNSPDMR Shareholding
16th Apr 20207:00 amRNSFinal Results and Notice of AGM
31st Mar 20207:00 amRNSUpdate re COVID-19 and Annual Accounts
6th Mar 20202:15 pmRNSPDMR Shareholding
20th Jan 20207:00 amRNSPortfolio Update
27th Dec 20193:29 pmRNSPDMR Shareholding
17th Oct 20194:40 pmRNSHolding(s) in Company
17th Oct 20192:37 pmRNSHolding(s) in Company
17th Sep 20197:00 amRNSHalf-year Report
22nd Aug 20197:00 amRNSPortfolio Update
30th Jul 20193:00 pmRNSResult of Annual General Meeting
10th Jul 201912:32 pmRNSDirector/PDMR Shareholding
9th Jul 20197:00 amRNSDividend Declaration
28th Jun 20197:00 amRNSPortfolio Update
27th Jun 20197:00 amRNSAnnual Financial Report and Notice of AGM
21st Jun 20199:30 amRNSLaunch of new website
26th Feb 20197:00 amRNSInvestment in MEL Science
11th Jan 20197:00 amRNSReceipt of $22.3 million in respect of disposal
2nd Jan 20197:00 amRNSDisposal of interest in Wrike and portfolio update
30th Nov 20182:52 pmRNSPortfolio company update
2nd Nov 20187:00 amRNSChange of Adviser
31st Oct 20181:45 pmRNSHolding(s) in Company
23rd Oct 20187:00 amRNSStatement re Portfolio Update
20th Aug 20187:00 amRNSDirector/PDMR Shareholding
16th Aug 20187:00 amRNSHalf-year Report
5th Jul 20187:00 amRNSInvestor Presentation
30th May 20187:00 amRNSStatement re Portfolio Revaluations
30th Apr 20184:45 pmRNSTotal Voting Rights
27th Apr 20181:28 pmRNSResult of AGM
29th Mar 201812:02 pmRNSConfirmation of Subscription
29th Mar 20187:00 amRNSPlacing and Proposed Subscription
15th Mar 20181:50 pmRNSNotice of AGM
15th Mar 20189:00 amRNSFinal Results
23rd Feb 20187:00 amRNSNotice of Results
21st Feb 20187:00 amRNSTMT Participation in Telegram Group, Inc. Pre-ICO
9th Jan 20185:52 pmRNSDirector/PDMR Shareholding
8th Jan 20183:11 pmRNSStmnt re Share Price Movement
7th Dec 20177:00 amRNSProposed participation in a new fund
17th Nov 20179:14 amRNSHolding(s) in Company
17th Nov 20178:13 amRNSInvestor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.